🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, non-randomized, single-arm, open-label, phase Ib, d...
Status
Recruiting
Location
Hoag Memorial Hospital Presbyterian
Start Date
2025-04-14
Trial ID
NCT06673017
Treatments Being Tested
This phase I trial studies the side effects and best dose of nortriptyline ...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-11-03
Trial ID
NCT02881125
Treatments Being Tested
The purpose of this study is to compare the survival and toxicity of TPC (T...
Status
Completed
Location
SunYat-senU
Start Date
2016-10-20
Trial ID
NCT02940925
Treatments Being Tested
This study aims to optimize neoadjuvant therapy for HER2-positive breast ca...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06973525
Treatments Being Tested
The purpose of this study is to compare the efficacy of pembrolizumab + len...
Status
Completed
Location
Anhui Cancer Hospital-Gynecological Oncology ( Site 2509)
Start Date
2019-10-22
Trial ID
NCT04865289
Treatments Being Tested
To observe the efficacy and toxicities of post-operative (R0/R1) proton rad...
Status
Recruiting
Location
Shanghai Proton and Heavy Ion Center
Start Date
2024-05-06
Trial ID
NCT06311968
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in differen...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-02
Trial ID
NCT00313599
Treatments Being Tested
This is an open-label, parallel controlled, phase IIa exploratory study tha...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07-15
Trial ID
NCT04446663
Treatments Being Tested
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06404463
This study is looking to see whether the combination of Tucidinostat and na...
Status
Unknown
Location
Hunan Cancer Hospital
Start Date
2023-02-07
Trial ID
NCT05633914
Treatments Being Tested